A Trial to Evaluate the Pharmacokinetics of ABL001 in Healthy and Hepatic Impaired Subjects
Clinical trial NCT02857868 · COMPLETED
Trial details
- NCT number
- NCT02857868
- Sponsor
- Novartis Pharmaceuticals
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2016-05-03
- Primary completion
- 2017-07-20
- Enrollment
- 32
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.